IBRX

ImmunityBio, Inc. $8.37 1M +9.4% 3M +17.9% YTD +314.4% as of 2026-09-14
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.3%
Next 1 week
-0.7%
Next 1 month
-1.1%
Seasonality
Weak window historically
Next 30 days (to Oct 15): -4.5% median, 30% of the last 10 years finished up.
20-year seasonality chart →
Mean reversion
Overbought — RSI(2) at 83
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.40%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.60 -0.7% · Seasonal tilt (10y) -0.4%
$67M/day volume 105% volatility +223% 1-year -82% from ATH
52-week range · 61% of the way up · -33% from the high
$1.95$12.43

Congressional trades in IBRX Full tracker →

1 member · 0 buys / 1 sells · $1K–$15K disclosed · latest filing Apr 17, 2023.

SELL DG Daniel Goldman · traded Mar 6, 2023 $1K–$15K

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.